Protalix BioTherapeutics TASE:PLX Rapport sur les actions
Dernier prix
₪7.33
Capitalisation boursière
₪407.5m
7D
-0.1%
1Y
97.5%
Mise à jour
23 Mar, 2023
Données
Finances de l'entreprise +
Protalix BioTherapeutics, Inc.
TASE:PLX Rapport sur les actions
Capitalisation boursière : ₪407.5m
This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
PLX Aperçu des actions
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally.